3 Mid-Cap Growth Stocks With Monstrous Long-Term Upside
Investing in stocks with modest valuations can set investors up for some significant returns in the long run. While there is more risk involved in putting money into smaller, less-established businesses, the upside can also be considerable, potentially resulting in massive gains.
Three mid-cap stocks that may have a lot of room to rise higher in the future are Archer Aviation (NYSE: ACHR), CRISPR Therapeutics (NASDAQ: CRSP), and e.l.f. Beauty (NYSE: ELF). Here are the big risks and opportunities that come with these stocks.
Image source: Getty Images.
Source Fool.com
CRISPR Therapeutics AG Stock
€46.59
4.000%
The community is currently still undecided about CRISPR Therapeutics AG with 2 Buy predictions and 0 Sell predictions.
With a target price of 200 € there is potential for a 329.32% increase which would mean more than doubling the current price of 46.59 € for CRISPR Therapeutics AG.
